基本信息 产品详情 公司简介 推荐产品
网站主页 (S,R,S)-AHPC-三聚乙二醇-氨基盐酸盐
  • (S,R,S)-AHPC-PEG3-NH2 hydrochloride (VH032-PEG3-NH2 hydrochloride)

(S,R,S)-AHPC-PEG3-NH2 hydrochloride (VH032-PEG3-NH2 hydrochloride)

新品
(S,R,S)-AHPC-PEG3-NH2 hydrochloride (VH032-PEG3-NH2 hydrochloride)
询价 10mg 起订
25mg 起订
50mg 起订
浙江 更新日期:2026-10-06

杭州埃米尔生物技术有限公司

VIP1年
联系人:沈忠
电话:19011298796拨打
手机:19011298796 拨打
邮箱:17816380947@139.com

产品详情:

英文名称:
(S,R,S)-AHPC-PEG3-NH2 hydrochloride (VH032-PEG3-NH2 hydrochloride)
CAS号:
2097971-11-2
品牌:
EMERTH
产地:
Hangzhou
保存条件:
-20°C
纯度规格:
98%
产品类别:
PROTACs

(S,R,S)-AHPC-PEG3-NH₂ hydrochloride (CAS No. 2097971-11-2), also known as VH032-PEG3-NH₂ hydrochloride, is an E3 ligase ligand-linker conjugate containing a VHL-targeting (S,R,S)-AHPC ligand, a flexible PEG3 linker, and a terminal amino group in hydrochloride salt form. It is a useful building block for the synthesis of PROTACs (Proteolysis Targeting Chimeras) and other targeted protein degradation molecules.

The VHL ligand moiety enables recruitment of the von Hippel–Lindau (VHL) E3 ubiquitin ligase, while the PEG3 linker provides a flexible spacer for connecting the E3 ligase ligand to a target-protein ligand. The terminal amino group provides a functional site for further chemical modification and conjugation.

(S,R,S)-AHPC-PEG3-NH₂ hydrochloride can therefore be used as a VHL E3 ligase recruiter and PROTAC building block in targeted protein degradation, medicinal chemistry, linker optimization, and bioconjugation research.

  • Synonyms: VH032-PEG3-NH₂ hydrochloride; VHL Ligand-Linker Conjugates 1 hydrochloride; E3 Ligase Ligand-Linker Conjugates 5

  • CAS No.: 2097971-11-2

  • Molecular Formula: C₃₀H₄₆ClN₅O₇S

  • Molecular Weight: 656.23 g/mol

  • Applications: PROTAC synthesis, VHL E3 ligase recruitment, targeted protein degradation, linker development, bioconjugation, and medicinal chemistry research.

  • For research use only. Not for human or clinical use.

PROTAC;PEG linker;VHL E3 ligase ligand;

公司简介

杭州埃米尔生物技术有限公司位于浙江省杭州市钱塘区下沙街道安和药谷,立足杭州生物医药产业集聚区位优势,专注深耕ADC/XDC 生物偶联技术研发服务、医药小分子中间体定制合成两大核心业务,是聚焦抗体偶联药物上下游研发配套的专业化生物技术初创企业,面向药企、CRO 公司、高校科研院所提供从工艺开发、样品合成到质控分析的一站式技术外包解决方案。

成立日期 (1年)
注册资本 200万人民币
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,试剂,定制,服务
主营行业 合成材料中间体,生物技术服务,技术培训服务,整体实验外包服务

(S,R,S)-AHPC-PEG3-NH2 hydrochloride (VH032-PEG3-NH2 hydrochloride)相关厂家报价

内容声明
拨打电话 立即询价